Key facts
- Zerapy’s last known valuation is $75.0M (Dec 2024).
- It has raised $850K; the latest was Angel (individual) ($800K) in Dec 2024.
- Notable investors include CREATE-X.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zerapy
- ·The full record, as it builds
Funding rounds
No funding rounds for Zerapy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zerapy
Developer of an AI-powered health technology platform designed to transform physical therapy and rehabilitation through advanced computer vision solutions. The company offers a proprietary SaaS platform that enables real-time motion assessment, personalized treatment planning, and remote therapeutic monitoring using only a smartphone camera, enabling healthcare providers, enterprises, and individuals to enhance rehabilitation outcomes, improve patient engagement, and streamline clinical operations.
- Sector
- Healthcare
- HQ
- Reston, VA, United States
- Founded
- 2023
- Employees
- 8
- Website
- zerapy.ai/
- Ownership
- Privately Held (backing)
Zerapy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zerapy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zerapy in its N-PORT filings yet. We sweep new filings monthly.